LTT Bio-Pharma Co., Ltd.【JP:E00982】Cash flow
Market cap
P/E ratio
| 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Depreciation & amortization | 1 | 1 | - | - | - | - | - | - | - | - | - |
| Cash from operations | 116 | 1,526 | 1,616 | 557 | 284 | 57 | 222 | -236 | 64 | 356 | -95 |
| Capital expenditures | -1 | -1 | -2 | -1 | -2 | -0 | -2 | -2 | -1 | -2 | -22 |
| Cash from investing | -201 | -303 | 198 | -301 | -807 | -300 | 197 | 296 | -403 | 41 | -33 |
| Payments for dividends | - | -255 | -1 | -257 | -257 | -1 | -257 | -1 | -0 | -127 | -0 |
| Cash from financing | - | -255 | -1 | -257 | -257 | -1 | -257 | -1 | -0 | -127 | -0 |